President and chief executive officer, Bellicum Pharmaceuticals
Developing Safer, Next-Generation CAR T-Cell Therapies
Rick Fair, president and chief executive officer, Bellicum Pharmaceuticals, discussed the company’s programs and future plans.
Developing Customizable CAR T-Cell Therapies
Rick Fair, president and chief executive officer, Bellicum Pharmaceuticals, discussed the company’s GoCAR, iMC, and caspaCIDe technologies.
